Our Response to COVID-19
Our Global Response
As new variants of SARS-CoV-2 arise, the global response must change and adapt. Tracking the infection and our immune response towards it becomes increasingly important.
Quansys Biosciences has recently introduced the new Q-Plex™ Human SARS-CoV-2 IgG (5-Plex) which detects antibodies specific for the nucleocapsid in addition to the spike glycoproteins S1 and S2. This allows researchers to distinguish between antibodies gained through vaccination and those that arose against a natural infection.
The new Q-Plex™ Human SARS-CoV-2 IgG (5-Plex) is one of several assays offered by Quansys Biosciences to support research on SARS-CoV-2. As vaccinations against SARS-CoV-2 become more prevalent worldwide many look forward to a return to normalcy.
Similar Kits Available
NEW! Q-Plex™ SARS-CoV-2 Human IgG (5-Plex)
Q-Plex™ SARS-CoV-2 Human IgG (4-Plex)
Q-Plex™ Human Cytokine Release Syndrome (16-Plex)
Q-Plex™ Human Cytokine – Screen (16-Plex)
For more information about these assays and for a complete list of available assays for research, please visit our analyte list page. For further questions or inquiries, reach out by emailing info@quansysbio.com or over the phone at (435) 752-0531.
As researchers and problem solvers ourselves, we understand the value of sound data. We are proud to be a part of research that can better the world. We value the relationships, partnerships, and friendships that we have built with the people who trust and use our technology. We are committed to building these relationships. You can count on us to answer the phone and take time to thoroughly address questions or concerns about any of our products. In an industry that is reputed for grandiose claims, we trust that our quality standards and our customer service set us apart from the competition. If you’re happy with our products or if you think we can do something better, we hope you will let us know.